Search
Hypertension Paid Clinical Trials in Wyoming
A listing of 1 Hypertension clinical trials in Wyoming actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
The state of Wyoming currently has 1 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including Sheridan, Cody, Casper and Cheyenne.
Featured Trial
High blood pressure (Hypertension) Clinical Study
Recruiting
A clinical study for people that suffer with High blood pressure (Hypertension)
Conditions:
High blood pressure (Hypertension)
Featured Trial
Stroke Clinical Study
Recruiting
A clinical study for people that suffer with Stroke
Conditions:
Stroke
Featured Trial
Chronic Kidney Disease (CKD) Clinical Study
Recruiting
A clinical study for people that suffer with Chronic Kidney Disease (CKD)
Conditions:
Chronic Kidney Disease (CKD)
Featured Trial
Cardiovascular Disease Clinical Study
Recruiting
A clinical study for people that suffer with Cardiovascular Disease
Conditions:
Cardiovascular Disease
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Hyperlipidemia Clinical Study
Recruiting
A clinical study for people that suffer with Hyperlipidemia
Conditions:
Hyperlipidemia
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Recruiting
This is a randomized, double-blind, two-treatment, single-period, parallel design, multiple dose at multiple clinical trial sites designed to demonstrate bioequivalence with clinical endpoint in subjects with chronic open-angle glaucoma or ocular hypertension in both eyes.
Test Product - Bimatoprost ophthalmic solution, 0.01% of Amneal EU, Limited Reference Product - LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of Allergan, Inc.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/09/2022
Locations: Cheyenne Eye Clinic & Surgery Center, Cheyenne, Wyoming
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
1 - 1 of 1